Form CERT - Certification by an exchange approving securities for listing:
SEC Accession No. 0001143313-24-000088
Filing Date
2024-09-12
Accepted
2024-09-12 13:57:35
Documents
1
Effectiveness Date
2024-09-12

Document Format Files

Seq Description Document Type Size
1 NYSE AMERICAN CERTIFICATION KAPA091224.pdf CERT 282748
  Complete submission text file 0001143313-24-000088.txt   390663
Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Filer) CIK: 0001962011 (see all company filings)

EIN.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERT | Act: 34 | File No.: 001-42275 | Film No.: 241294553
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)